Xiangjun Tang

737 total citations
28 papers, 552 citations indexed

About

Xiangjun Tang is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Xiangjun Tang has authored 28 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Xiangjun Tang's work include Glioma Diagnosis and Treatment (6 papers), RNA Interference and Gene Delivery (4 papers) and Virus-based gene therapy research (3 papers). Xiangjun Tang is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), RNA Interference and Gene Delivery (4 papers) and Virus-based gene therapy research (3 papers). Xiangjun Tang collaborates with scholars based in China, United States and Canada. Xiangjun Tang's co-authors include Long‐Jun Dai, Kuan-Ming Huang, Li Zhang, Jie Luo, Garth L. Warnock, Zhuoshun Yang, Xuyong Sun, Qianxue Chen, Bin Wang and Li Du and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Xiangjun Tang

27 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangjun Tang China 15 309 119 97 93 89 28 552
Qing Shi China 12 291 0.9× 115 1.0× 102 1.1× 95 1.0× 75 0.8× 39 602
Sandy Azzi France 13 330 1.1× 137 1.2× 97 1.0× 200 2.2× 149 1.7× 18 693
Amir Barzegar Behrooz Iran 13 387 1.3× 189 1.6× 97 1.0× 162 1.7× 58 0.7× 34 686
Arijit Bhowmik India 11 381 1.2× 108 0.9× 100 1.0× 147 1.6× 41 0.5× 27 686
Ana R. Rama Spain 15 301 1.0× 138 1.2× 74 0.8× 194 2.1× 47 0.5× 33 555
Sujan Kumar Mondal United States 14 316 1.0× 105 0.9× 112 1.2× 72 0.8× 71 0.8× 28 540
Guangqiang Li China 16 489 1.6× 183 1.5× 92 0.9× 61 0.7× 92 1.0× 24 830
Yunzhen Gao China 12 206 0.7× 91 0.8× 91 0.9× 68 0.7× 107 1.2× 18 436
Shahram Torkamandi Iran 9 233 0.8× 104 0.9× 58 0.6× 49 0.5× 58 0.7× 21 459
Cristina Jiménez‐Luna Spain 14 333 1.1× 171 1.4× 103 1.1× 221 2.4× 60 0.7× 34 701

Countries citing papers authored by Xiangjun Tang

Since Specialization
Citations

This map shows the geographic impact of Xiangjun Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjun Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjun Tang more than expected).

Fields of papers citing papers by Xiangjun Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangjun Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjun Tang. The network helps show where Xiangjun Tang may publish in the future.

Co-authorship network of co-authors of Xiangjun Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangjun Tang. A scholar is included among the top collaborators of Xiangjun Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangjun Tang. Xiangjun Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Zhouqi, Xingchun Gao, Xiangjun Tang, et al.. (2025). Signal Transducer Nanoparticles Enable Siglec‐10/G Blockade Immunotherapy for Breast Cancer Treatment. Advanced Materials. 37(39). e2502758–e2502758. 1 indexed citations
2.
Tang, Xiangjun, Caroline Tang, Fei Cao, et al.. (2025). A lupus-derived autoantibody that binds to intracellular RNA activates cGAS-mediated tumor immunity and can deliver RNA into cells. Science Signaling. 18(879). eadk3320–eadk3320. 4 indexed citations
3.
4.
Mohammed, Farrah S., et al.. (2024). Nanotechnology approaches to drug delivery for the treatment of ischemic stroke. Bioactive Materials. 43. 145–161. 7 indexed citations
5.
Gao, Xingchun, Xiangjun Tang, Zewei Tu, et al.. (2024). Tertiary amine modification enables triterpene nanoparticles to target the mitochondria and treat glioblastoma via pyroptosis induction. Biomaterials. 317. 123035–123035. 6 indexed citations
6.
Tang, Xiangjun, Jing Zhu, Aiping Deng, et al.. (2022). Case Report: Primary Pulmonary Angiosarcoma With Brain Metastasis. Frontiers in Bioengineering and Biotechnology. 9. 803868–803868.
7.
Tang, Xiangjun, Hao Peng, Li Zhang, et al.. (2022). Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy. Molecular Therapy — Oncolytics. 24. 707–718. 16 indexed citations
8.
Ye, Zhang, Jiayang Cai, Yixuan Wang, et al.. (2022). Esterase-Responsive and Size-Optimized Prodrug Nanoparticles for Effective Intracranial Drug Delivery and Glioblastoma Treatment. SSRN Electronic Journal. 2 indexed citations
9.
Peng, Hao, Xingrong Guo, Chao Duan, et al.. (2021). Intracranial delivery of synthetic mRNA to suppress glioblastoma. Molecular Therapy — Oncolytics. 24. 160–170. 23 indexed citations
10.
Xie, Shiwei, Chenyang Zhao, Wei Chen, et al.. (2021). Recombinant human bone morphogenetic protein 2 and 7 inhibit the degeneration of intervertebral discs by blocking the Puma-dependent apoptotic signaling. International Journal of Biological Sciences. 17(9). 2367–2379. 14 indexed citations
11.
Tang, Xiangjun, Pengfei Xu, Ann Chen, et al.. (2020). Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform. Frontiers in Genetics. 11. 514363–514363. 7 indexed citations
12.
Zhu, Yuyan, Hailin Tang, Li Zhang, et al.. (2019). Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing PI3K/Akt/Bad cascade via regulating PTEN. SHILAP Revista de lepidopterología. 3 indexed citations
13.
Jiang, Peng, Jie Luo, Ping‐Ji Deng, et al.. (2019). kmcEx: memory-frugal and retrieval-efficient encoding of counted k-mers. Bioinformatics. 35(23). 4871–4878. 2 indexed citations
14.
Tang, Xiangjun, Pengfei Xu, Bin Wang, et al.. (2019). Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients. Frontiers in Oncology. 9. 812–812. 19 indexed citations
15.
Tang, Xiangjun, Shenqi Zhang, Rui Fu, et al.. (2019). Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma. Frontiers in Oncology. 9. 1208–1208. 54 indexed citations
16.
Wang, Gang, Junjie Wang, Xiangjun Tang, Li Du, & Fei Li. (2016). In vitro and in vivo evaluation of functionalized chitosan–Pluronic micelles loaded with myricetin on glioblastoma cancer. Nanomedicine Nanotechnology Biology and Medicine. 12(5). 1263–1278. 60 indexed citations
17.
Wang, Gang, Xingli Fu, Junjie Wang, Rui Guan, & Xiangjun Tang. (2016). Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma. Current Cancer Drug Targets. 17(1). 17–39. 11 indexed citations
18.
Tang, Xiangjun, Gang Cao, Jie Luo, et al.. (2016). Protective effect of microRNA-138 against cerebral ischemia/reperfusion injury in rats. Experimental and Therapeutic Medicine. 11(3). 1045–1050. 31 indexed citations
19.
Luo, Jie, Xingrong Guo, Xiangjun Tang, et al.. (2013). Intravital biobank and personalized cancer therapy: The correlation with omics. International Journal of Cancer. 135(7). 1511–1516. 14 indexed citations
20.
Zeng, Xian‐Tao, Xiangjun Tang, Xuejun Wang, et al.. (2012). AlloDerm implants for prevention of Frey syndrome after parotidectomy: A systematic review and meta-analysis. Molecular Medicine Reports. 5(4). 974–980. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Shi Breakdown of academic impact, for papers by Sandy Azzi Breakdown of academic impact, for papers by Amir Barzegar Behrooz Breakdown of academic impact, for papers by Arijit Bhowmik Breakdown of academic impact, for papers by Ana R. Rama Breakdown of academic impact, for papers by Sujan Kumar Mondal Breakdown of academic impact, for papers by Guangqiang Li Breakdown of academic impact, for papers by Yunzhen Gao Breakdown of academic impact, for papers by Shahram Torkamandi Breakdown of academic impact, for papers by Cristina Jiménez‐Luna
Rankless by CCL
2026